Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

523
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
523
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

71.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.9K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

722
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
722
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

555
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
555
Anatomy of the Intestines01:23

Anatomy of the Intestines

72.8K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.8K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.0K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced broad-band intermuscular coherence in myoclonus: a targeted characterization study.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Nature medicine·2026
Same author

Hand-Specific Engagement of Cerebello-Thalamo-Cortical and Higher-Order Sensorimotor Networks in Essential Tremor: Converging Evidence From GLM and MVPA-Based fMRI Analysis.

European journal of neurology·2026
Same author

Machine learning based EMG analysis of intermuscular coherence and cumulant density in tremor and myoclonus.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Discrepancies between patient-reported and physician-reported severity and disability in functional and non-functional movement disorders.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Vitamin B<sub>12</sub> Supplementation: Is More Always Better?

Nutrients·2026

Related Experiment Video

Updated: Aug 10, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.4K

Gut Microbiome Composition in Dystonia Patients.

Elze R Timmers1,2, J Casper Swarte3, Ranko Gacesa3

  • 1Department of Neurology, University Medical Center Groningen, University of Groningen, 9700RB Groningen, The Netherlands.

International Journal of Molecular Sciences
|February 11, 2023
PubMed
Summary

The gut microbiome may influence dystonia symptoms through the gut-brain axis. Dystonia patients showed altered gut bacteria and reduced neuro-active pathways like tryptophan degradation.

Keywords:
dystoniagut microbiomegut–brain axis

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.0K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.7K

Related Experiment Videos

Last Updated: Aug 10, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.4K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.0K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.7K

Area of Science:

  • Neuroscience
  • Microbiology
  • Genetics

Background:

  • Dystonia is a movement disorder characterized by involuntary movements and postures.
  • Non-motor symptoms, including psychiatric issues, sleep disturbances, and fatigue, are prevalent in dystonia patients.
  • The gut-brain axis is a potential pathway influencing neurological disorders.

Purpose of the Study:

  • To investigate the gut microbiome composition in dystonia patients compared to healthy controls.
  • To explore the abundance of neuro-active metabolic pathways potentially linked to dystonia symptoms.
  • To examine the relationship between the gut microbiome and (non-)motor symptoms in dystonia.

Main Methods:

  • Metagenomic and 16S rRNA sequencing of stool samples from dystonia subtypes (cervical dystonia, dopa-responsive dystonia, myoclonus-dystonia) and controls.
  • Analysis of gut microbiome diversity (alpha and beta).
  • Quantification of neuro-active metabolic pathways, including tryptophan degradation.

Main Results:

  • No significant differences in overall microbiome alpha and beta diversity between dystonia patients and controls.
  • Dystonia patients exhibited higher abundances of *Ruminococcus torques* and *Dorea formicigenerans*, and lower abundance of *Butyrivibrio crossotus* compared to controls.
  • Reduced abundance of neuro-active pathways, particularly tryptophan degradation, was observed in dystonia patients.
  • Non-motor symptoms and plasma neurotransmitter levels explained gut microbiome variance in dystonia.

Conclusions:

  • The gut microbiome composition differs between dystonia patients and controls.
  • Alterations in specific gut bacteria and neuro-active pathways suggest a role for the gut-brain axis in dystonia pathophysiology.
  • Further research is warranted to confirm these preliminary findings and elucidate the mechanisms involved.